Ticker	Volume	Price	Price Delta
DJIA	15,408.00	+72.76	0.47%
S&P 500	1,671.41	+5.12	0.31%
Nasdaq	3,506.15	+9.72	0.28%

Ticker

Volume

Price

Price Delta

DJIA

15,408.00

+72.76

0.47%

S&P 500

1,671.41

+5.12

0.31%

Nasdaq

3,506.15

+9.72

0.28%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.65	-2.85	-0.10%
FTSE 100	6,803.87	+48.24	0.71%
DAX	8,472.20	+16.37	0.19%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.65

-2.85

-0.10%

FTSE 100

6,803.87

+48.24

0.71%

DAX

8,472.20

+16.37

0.19%

Ticker	Volume	Price	Price Delta
Nikkei	15,381.00	+20.21	0.13%
Hang Seng	23,366.40	-126.66	-0.54%
S&P/ASX 200	5,180.06	-28.98	-0.56%

Ticker

Volume

Price

Price Delta

Nikkei

15,381.00

+20.21

0.13%

Hang Seng

23,366.40

-126.66

-0.54%

S&P/ASX 200

5,180.06

-28.98

-0.56%

Roche Won’t Revisit Illumina Purchase Offer, Chief Tells Sonntag

By Elena Logutenkova - 2012-06-10T12:19:20Z

Roche Holding AG (ROG) will not make a new purchase offer for Illumina Inc. (ILMN), Der Sonntag reported, citing an interview with Chief Executive Officer Severin Schwan.

Roche is focusing mostly on small and medium-sized acquisitions, Schwan told the newspaper. He also said he wouldn’t rule out acquisitions the size of Illumina if opportunities arise, the newspaper said.

To contact the reporter on this story: Elena Logutenkova in Zurich at elogutenkova@bloomberg.net

To contact the editor responsible for this story: Frank Connelly at fconnelly@bloomberg.net

More News:

Health Care

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.